Overview
Description
Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. The company was founded by Isaac Reckitt in 1840 and is headquartered in Slough, the United Kingdom.
Consumer Non-Cyclicals Household Products Personal Care and Cleaning Products United Kingdom
Financials
Key metrics
| Market capitalisation, EUR | 38,281 m |
| EPS, EUR | - |
| P/B ratio | 4.3 |
| P/E ratio | 10.6 |
| Dividend yield | 4.14% |
Income statement (2025)
| Revenue, EUR | 16,603 m |
| Net income, EUR | 3,738 m |
| Profit margin | 22.51% |
What ETF is Reckitt Benckiser Group Plc in?
There are 48 ETFs which contain Reckitt Benckiser Group Plc. All of these ETFs are listed in the table below. The ETF with the largest weighting of Reckitt Benckiser Group Plc is the iShares STOXX Europe 600 Personal & Household Goods UCITS ETF (DE).
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
